@article{62b7ff9137a74216919306dea889bed1,
title = "Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.",
author = "Trendowski, {Matthew R.} and Wheeler, {Heather E.} and Omar El-Charif and Feldman, {Darren R.} and Hamilton, {Robert J.} and Vaughn, {David J.} and Chunkit Fung and Christian Kollmannsberger and Einhorn, {Lawrence H.} and Travis, {Lois B.} and Dolan, {M. Eileen}",
note = "Purpose: Cisplatin is a first-line chemotherapeutic for many cancers, but causes neurotoxicity including hearing loss, tinnitus, and peripheral sensory neuropathy. However, no study has comprehensively characterized risk factors for developing multiple (>1) severe neurotoxicities. Experimental Design: The relationship between multiple severe neurotoxicities and age, cumulative cisplatin dose, medical history, and lifestyle/behavioral factors was evaluated in 300 cisplatin-treated testicular cancer survivors using logistic regression.",
year = "2020",
month = sep,
day = "30",
doi = "10.1158/1078-0432.CCR-20-2682",
language = "American English",
volume = "26",
journal = "Clinical Cancer Research",
issn = "1557-3265",
number = "24",
}